Forest’s Lexapro Okayed For Adolescents With Major Depressive Disorder
This article was originally published in The Pink Sheet Daily
Executive Summary
SSRI is only the second antidepressant approved for treatment in adolescents.
You may also be interested in...
Missing Clinical Trial Data: "Mixed Model" Approach Gains Ground At FDA
Clinical trial sponsors should adopt a mixed statistical model to cope with missing data rather than relying on the "last observation carried forward" model that was formerly perceived as regulators' favorite
Missing Clinical Trial Data: "Mixed Model" Approach Gains Ground At FDA
Clinical trial sponsors should adopt a mixed statistical model to cope with missing data rather than relying on the "last observation carried forward" model that was formerly perceived as regulators' favorite
Forest’s Lexapro Okayed For Adolescents With Major Depressive Disorder
SSRI is only the second antidepressant approved for treatment in adolescents.